{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T02:55:14Z","timestamp":1714618514562},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,28]]},"DOI":"10.7759\/cureus.30808","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T18:08:05Z","timestamp":1666980485000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19-Induced Sporadic Inclusion Body Myositis"],"prefix":"10.7759","author":[{"given":"Fazal","family":"Dalal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"McNew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas MC","year":"2006","unstructured":"Dalakas MC. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol. 2006, 2:437-47. 10.1038\/ncpneuro0261","journal-title":"Nat Clin Pract Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.36185\/2532-1900-032","article-title":"Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications","volume":"39","author":"Dalakas MC","year":"2020","unstructured":"Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol. 2020, 39:289-301. 10.36185\/2532-1900-032","journal-title":"Acta Myol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: an overview","volume":"15","author":"Raveendran AV","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021, 15:869-75. 10.1016\/j.dsx.2021.04.007","journal-title":"Diabetes Metab Syndr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13746","article-title":"Assessment and characterisation of post-COVID-19 manifestations","volume":"75","author":"Kamal M","year":"2021","unstructured":"Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021, 75:e13746. 10.1111\/ijcp.13746","journal-title":"Int J Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.6.1887","article-title":"Inclusion body myositis in HIV-1 and HTLV-1 infected patients","volume":"119","author":"Cupler EJ","year":"1996","unstructured":"Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain. 1996, 119:1887-93. 10.1093\/brain\/119.6.1887","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2008.01.011","article-title":"Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis","volume":"15","author":"Needham M","year":"2008","unstructured":"Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci. 2008, 15:1350-3. 10.1016\/j.jocn.2008.01.011","journal-title":"J Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400407","article-title":"Inclusion body myositis: clinical and pathological boundaries","volume":"40","author":"Amato AA","year":"1996","unstructured":"Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol. 1996, 40:581-6. 10.1002\/ana.410400407","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5069042","article-title":"Clinical, histological, and immunohistochemical findings in inclusion body myositis","volume":"2018","author":"de Camargo LV","year":"2018","unstructured":"de Camargo LV, de Carvalho MS, Shinjo SK, de Oliveira AS, Zanoteli E. Clinical, histological, and immunohistochemical findings in inclusion body myositis. Biomed Res Int. 2018, 2018:5069042. 10.1155\/2018\/5069042","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab","volume":"83","author":"Amato AA","year":"2014","unstructured":"Amato AA, Sivakumar K, Goyal N, et al.. Treatment of sporadic inclusion body myositis with bimagrumab. Neurology. 2014, 83:2239-46. 10.1212\/WNL.0000000000001070","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.0.CO;2-C","article-title":"Safety and efficacy of strength training in patients with sporadic inclusion body myositis","volume":"20","author":"Spector SA","year":"1997","unstructured":"Spector SA, Lemmer JT, Koffman BM, Fleisher TA, Feuerstein IM, Hurley BF, Dalakas MC. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve. 1997, 20:1242-8. 10.1002\/(SICI)1097-4598(199710)20:10&lt;1242::AID-MUS6&gt;3.0.CO;2-C","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000145834.17020.86","article-title":"Primary respiratory failure in inclusion body myositis","volume":"63","author":"Voermans NC","year":"2004","unstructured":"Voermans NC, Vaneker M, Hengstman GJ, ter Laak HJ, Zimmerman C, Schelhaas HJ, Zwarts MJ. Primary respiratory failure in inclusion body myositis. Neurology. 2004, 63:2191-2. 10.1212\/01.wnl.0000145834.17020.86","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113643-covid-19-induced-sporadic-inclusion-body-myositis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:27Z","timestamp":1707507807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113643-covid-19-induced-sporadic-inclusion-body-myositis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.30808","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}